Gamete membrane interactions begin with adhesion (binding) of the sperm to the oocyte plasma membrane and culminate with fusion of the membranes of the gametes, thus creating the zygote through the union of these two very different cells. This review summarizes the molecular and cell biology of the cell±cell interactions between mammalian gametes. Recent research studies have provided new insights into the complexity of these interactions and into the importance of multimeric molecular networks and optimal membrane order in both sperm and oocytes for successful fertilization. Molecules that will be highlighted include cysteine-rich secretory protein 1 (CRISP1) and ADAMs [fertilin a (ADAM1), fertilin b (ADAM2) and cyritestin (ADAM3)] on sperm, and integrins, CD9, and other integrin-associated proteins on oocytes, as well as other molecules. The characteristics of these gamete molecules are summarized, followed by discussions of the experimental data that provide evidence for their participation in gamete membrane interactions, and also of the speci®c roles that these molecules might play. Insights from a variety of research areas, including gamete biology, cell adhesion, and membrane fusion, are put together for a tentative model of how sperm±oocyte adhesion and fusion occur. The clinical relevance of correct gamete membrane interactions is also noted.
Introduction
Mammalian sperm interact with oocytes on three different levels during fertilization: (i) the cumulus layer; (ii) the zona pellucida (ZP), which induces exocytosis of sperm acrosome contents; and (iii) the oocyte plasma membrane, which begins with adhesion (or binding) to the oocyte plasma membrane and concludes with fusion of the sperm membrane with the oocyte membrane. This review will focus on this third level, the interactions between gamete membranes. This interaction is preceded by acrosomal exocytosis, which is triggered by sperm binding to the ZP and is a critical prerequisite step to sperm±oocyte membrane interactions. It not only gives the sperm access to the perivitelline space where membrane interactions take place, but also exposes and modi®es regions of the sperm surface to make the sperm capable of interacting with the oocyte membrane. Gamete membrane interactions involve a complex series of molecular interactions, beginning with initial attachment of the sperm to the oocyte, leading to ®rm cell±cell adhesion, and culminating in fusion of the two membranes, making one cell out of two. This review will address the cellular and molecular bases of these processes.
The main experimental method used to study the cellular and molecular mechanisms of sperm±oocyte interactions has been the IVF assay, examining sperm±oocyte interactions in experimentally manipulated conditions. For assessing gamete adhesion and fusion, ZP-free oocytes are usually used. The design of experiments with regard to insemination condition variables, assessment of sperm±oocyte adhesion and sperm±oocyte fusion, and interpretation of results from such assessments have been discussed (Evans, 1999) . Data from IVF experiments have been augmented by other work, including studies of cellular interactions (such as with cells transfected to express gamete proteins of interest) and molecular interactions (such as analyses of speci®c protein±protein interactions).
Most of what is known about gamete interactions has been derived from animal models. Many of the molecules involved in fertilization processes that have been identi®ed in mammalian model systems are conserved in humans. Studies of heterologous systems (sperm and oocytes from different species) can also be performed. ZP-free hamster oocytes are commonly used for studies of membrane interactions because they fuse with sperm from nearly every mammalian species tested (Yanagimachi, 1988) . It has generally been assumed that if a reagent (e.g. an antibody) inhibits the interaction of human sperm with hamster oocytes, then it would also inhibit the interaction of human sperm with human oocytes. While this is likely to apply in most cases, there are examples of`false positives' [i.e. a reagent that inhibits in the heterologous system but not in the homologous system (Primakoff and Hyatt, 1986) ] and`false negatives' [i.e. a reagent that inhibits in the homologous system but not in the heterologous system (Okabe et al., 1988) ]. Thus, care is necessary in the interpretation of results from the ZP-free hamster oocyte assays until more is known about the molecules involved in gamete membrane interactions. In addition, the fusibility of the hamster oocyte plasma membrane could be due to unique features of the biochemical nature of that particular membrane environment (lipids and/or proteins). As such factors are not yet completely understood, the relevance of the ZP-free hamster oocyte penetration test to bona ®de human sperm±oocyte membrane interactions remains to be determined.
How have molecules involved in gamete membrane interactions been identi®ed? The`candidate molecule' approach has been applied, basing studies of sperm±oocyte interactions on studies of other cell±cell interactions. For example, oocytes and sperm have been examined for the expression of known cell adhesion molecules, such as integrins, extracellular matrix proteins, cadherins and immunoglobulin superfamily cell adhesion molecules. Data exist that support the role of integrins in sperm±oocyte interactions (see below). In addition, some sperm molecules were identi®ed by what might be considered proteomic methods, used well before the word`proteome' was coined. One example of this is the generation of a collection of anti-sperm monoclonal antibodies that are likely to cross-react with surface epitopes by immunizing mice with intact sperm or to sperm membrane proteins. These antibodies are then screened for the ability to bind to sperm and to perturb sperm function (such as sperm±zona binding, sperm±oocyte interaction, etc.). Details of some of the molecules identi®ed by this and other methods are provided below.
Microscopic studies: key insights into sperm±oocyte membrane interactions
Early insights into gamete plasma membrane interactions came from elegant microscopic analyses, including light microscopy, scanning and transmission electron microscopy, and video microscopy (Yanagimachi, 1988 (Yanagimachi, , 1994 reviews) . The oocyte plasma membrane is covered with microvilli; in rodent oocytes, the region overlying the meiotic spindle is free of microvilli, and sperm±oocyte fusion rarely occurs in this region (Ebenspaecher and Barros, 1984) . Sperm interactions with the oocyte membrane also occur in a spatially restricted manner, with the inner acrosomal membraneÐwhich is exposed after the acrosome reactionÐcontacting the oocyte membrane ®rst (Huang and Yanagimachi, 1985) . Subsequently, the equatorial segment and the posterior head of the sperm adhere to and then fuse with the oocyte membrane (Yanagimachi and Noda, 1970; Bedford et al., 1979) . In the rodent, acrosome-intact sperm can adhere to the oocyte membrane, but only acrosome-reacted sperm fuse with the oocyte membrane (Yanagimachi and Noda, 1970; Phillips and Yanagimachi, 1982) . In human sperm, there is evidence that the acrosome reaction is important for adhesion to the oocyte membrane (Talbot and Chacon, 1982; Bronson et al., 1999a) . Initial attachments of the sperm to the oocyte membrane are reversible and appear to require sperm motility (Wolf and Armstrong, 1978) , although sperm with poor motility can fuse with oocytes (Yanagimachi, 1988) . Sperm tail movement decreases or stops within a few seconds of sperm±oocyte fusion (Wolf and Armstrong, 1978) . Electron microscopy shows that the inner acrosomal membrane is later engulfed by the oocyte through a process that appears similar to phagocytosis (Huang and Yanagimachi, 1985) . The sperm tail is also eventually incorporated into the oocyte (Hirao and Hiraoka, 1987) .
Molecules that mediate gamete membrane interactions
Sperm-associated cysteine-rich secretory protein 1 (CRISP1) (DE, AEG-1 and ARP)
The protein known as DE was identi®ed in rat epididymal protein lysates in an analysis of proteins expressed in the epididymis in an androgen-dependent manner (Cameo and Blaquier, 1976) . The protein complex gets its name from two bands, D and E, on a denaturing polyacrylamide gel. Proteins D and E co-purify, are antigenically related, and are likely variants of the same gene product based on the high amino acid identity between tryptic peptides of protein D and protein E, although there are some differences between D and E (including size, high-performance liquid chromatographic separation of tryptic peptides, monoclonal antibody recognition and epididymal expression patterns) (Brooks, 1982; Xu and Hamilton, 1996) . The molecular basis of the differences between proteins D and E is not known.
The peptide sequences of proteins D and E in the rat (Xu and Hamilton, 1996; Cohen et al., 2000b) and the mouse epididymal protein (MEP)-7 epididymal antigen in the mouse (Rankin et al., 1992) match the deduced amino acid sequence of previously characterized cDNA clones, an androgen-regulated sperm-coating epididymal protein in rat and rat acidic epididymal glycoprotein (AEG)-1 (Brooks et al., 1986; Charest et al., 1988) . With the identi®cation of additional related proteins in several mammalian species, this family has come to be known as the CRISP family. Family members include DE-like proteins expressed in the epididymis (Haendler et al., 1993; Eberspaecher et al., 1995; Kra Ètzschmar et al., 1996a; Sivashanmugam et al., 1999) , another family member, CRISP2, expressed primarily in the testis (also known as Tpx-1) (Kasahara et al., 1989; Foster and Gerton, 1996; Kra Ètzschmar et al., 1996a; O'Bryan et al., 1998) , and another, CRISP3, with variable tissue distribution (Mizuki and Kasahara, 1992; Haendler et al., 1993; Kra Ètzschmar et al., 1996a; Schambony et al., 1998a) . Cysteine-rich carboxy-terminal portions are present in all CRISPs, and the overall amino acid identities between CRISP family members range from~30% to >80%. Epididymal proteins D and E are believed to be two forms of rat CRISP1. Mammalian CRISPs are closely related to certain toxins in reptiles. The vertebrate CRISPs are more distantly related to pathogenesis-related proteins (PR1) in plants and similar proteins in fungi; venom polypeptides in insects; and a Xenopus sperm chemoattractant protein that is synthesized in the oviduct and deposited with oocyte jelly coat (Foster and Gerton, 1996; Hayashi et al., 1996; Olson et al., 2001) .
CRISP1/DE has been studied most extensively in the rat and, unless otherwise noted, the data discussed below refer to that species. CRISP1 is synthesized by the epididymis and associates with rat sperm during epididymal transit. Expression of the D and E forms of CRISP1 protein varies by epididymal region (Brooks, 1982; Moore et al., 1994) , although the differences do not seem to be due to alternative splicing of CRISP1 mRNA (Klemme et al., 1999; Roberts et al., 2001) . Most association of CRISP1 with sperm is evident in sperm retrieved from the distal corpus and cauda epididymis (Moore et al., 1994) . There appear to be twò levels' of CRISP1 association with sperm. The majority of CRISP1 is loosely associated with rat sperm, and is released during capacitation in vitro (Cohen et al., 2000b) or by biochemical extraction treatments (Kohane et al., 1980; Rankin et al., 1992; Kra Ètzschmar et al., 1996a) . A fraction of CRISP1 may be tightly associated with rat sperm (Wong and Tsang, 1982; Moore et al., 1994; Cohen et al., 2000b) , although the amount of CRISP1 that remains associated with sperm and/or the strength of the association may vary by species (Rankin et al., 1992; Kra Ètzschmar et al., 1996a; Cohen et al., 2001) . Other CRISP family proteins expressed in the male reproductive tract may associate with sperm in some species (Schambony et al., 1998b) . It is not known how rat CRISP1 associates with the sperm membrane; there are data to indicate that rat sperm-associated CRISP1 is not attached through a glycosylphosphatidylinositol (GPI) linkage, directly or indirectly (i.e. to a GPI-linked binding partner) (Moore et al., 1994) . Immuno¯uorescence data show that sperm-associated CRISP1 is localized on the dorsal region of the acrosome of cauda epididymal rat and mouse sperm Cohen et al., 2000a) ; with one antibody, it is detected on the tail of cauda epididymal and ejaculated rat sperm (Moore et al., 1994; Xu et al., 1997) . On capacitated and acrosome-reacted rat sperm, CRISP1 is detected on the equatorial segment . In ejaculated sperm from the horse, human and rhesus monkey, CRISP proteins are detected on the principal piece and mid-piece of the tail as well as the posterior (post-acrosomal) region of the sperm head (Hayashi et al., 1996; Schambony et al., 1998b; Sivashanmugam et al., 1999) .
CRISP1 has been implicated in rodent gamete membrane interactions. Anti-DE antibodies inhibit fertilization of rat oocytes, either when mixed with rat sperm before the sperm are used for arti®cial insemination (Cuasnicu et al., 1984) or in IVF (Cuasnicu et al., 1990) . Additionally, CRISP1 protein puri®ed from rat epididymal extracts binds to the plasma membrane of rat and mouse oocytes, and rat oocytes and mouse oocytes treated with puri®ed rat CRISP1 show reduced levels of fertilization when mixed with sperm in IVF Cohen et al., 2000a) . Male rats immunized with CRISP1 show reduced fertility in mating trials, as well as the presence of anti-CRISP1 antibodies in epididymal and vas deferens¯uids; sperm from these immunized males could adhere to but not fuse with ZP-free oocytes (Ellerman et al., 1998) . In agreement with this, puri®ed CRISP1 was found to inhibit rat sperm±oocyte fusion but was apparently without effect on sperm±oocyte adhesion Ellerman et al., 1998) . A CRISP protein might also participate in human gamete membrane interactions. A human epididymal protein with some homology to rat CRISP1 (38% amino acid identity) has been described as AEG-related protein (ARP) or the human orthologue of rat CRISP1 (Hayashi et al., 1996; Kra Ètzschmar et al., 1996a) ; a similar protein has also been characterized in the rhesus monkey (Sivashanmugam et al., 1999) . There are con¯icting data regarding how much ARP is tightly associated with human sperm. Some biochemical extraction data suggest that no ARP is tightly associated (Kra Ètzschmar et al., 1996a) , while other biochemical extraction data suggest that a subset of ARP is tightly associated and immuno¯uorescence detects ARP antigen on the heads and tails of ejaculated human and monkey sperm (Hayashi et al., 1996; Sivashanmugam et al., 1999) . Human ARP is implicated in human gamete membrane interactions by the observation that human sperm treated with anti-human ARP antibodies show a reduced ability to fertilize hamster oocytes . In addition, a recombinant form of this protein binds to the plasma membrane of human oocytes . However, it is not known if there is a binding partner on the oocyte membrane for sperm-associated CRISP proteins, and the mechanism by which CRISP proteins participate in gamete membrane interactions remains uncharacterized.
Sperm ADAMs: fertilin b (ADAM2), fertilin a (ADAM1) and cyritestin (ADAM3)
Fertilin b was ®rst implicated in gamete membrane interactions because it was identi®ed as the antigen of an antibody, PH-30, that blocked fertilization of guinea pig oocytes (Primakoff et al., 1987) . This antibody was made as described above, by immunizing mice with a guinea pig sperm membrane preparation to generate a battery of monoclonal antibodies that recognize sperm surface antigens (Primakoff and Myles, 1983) . Fertilin a was identi®ed and characterized with fertilin b, since these two proteins form a heterodimer (Primakoff et al., 1987; Waters and White, 1997; Cho et al., 2000) . In turn, cyritestin was identi®ed in the mouse and monkey by various cloning strategies (Barker et al., 1994; Wolfsberg et al., 1995; Heinlein et al., 1996) . All have since been identi®ed in rodents and primates, and fertilin b and fertilin a have also been identi®ed in bovine and rabbit species.
The signi®cant homologies and conserved domain structure of these and related proteins led to the identi®cation of the molecular family known as ADAMs (an acronym for a disintegrin and a metalloprotease domain); the terms MDC (for metalloproteasedisintegrin-cysteine rich), metalloprotease-disintegrin and cellular disintegrin are also used in the literature. Fertilin a, fertilin b and cyritestin are known as ADAM1, ADAM2 and ADAM3 respectively. Approximately 30 members of this molecular family have been identi®ed to date in vertebrates, expressed in a wide range of tissues and cell types. ADAM proteins are also present in invertebrates such as Drosophila and Caenorhabditis elegans . ADAM proteins, like the name suggests, have a speci®c domain structure: a signal sequence, prodomain, metalloprotease domain, disintegrin-like domain, cysteine-rich domain, an epidermal growth factor (EGF)-like repeat, and a transmembrane segment with a short cytoplasmic tail. The disintegrin-like domains of these proteins have generated great interest. These domains have homology to snake venom ligands for the integrin family of cell adhesion molecules (Gould et al., 1990; McLane et al., 1998; Evans, 2001 ), suggestive of a role for these sperm proteins in cell adhesion (discussed below). Many of the snake venom polypeptides contain an RGD tripeptide, similar to that recognized by eight of the 24 known integrins (Evans, 2001; summary) , although virtually no ADAMs have an RGD in this region. Nevertheless, this region in disintegrin domains is sometimes referred to as the`disintegrin loop', since the RGD motif is on a loop structure in some snake disintegrins.
The ADAM protein family has dual functionality. Some family members have important proteolytic activities and others function as cell adhesion molecules (Black and White, 1998; Primakoff and Myles, 2000) , although the speci®c functions of many of these ADAM proteins remain to be fully characterized. This review will focus exclusively on ADAM proteins involved in adhesion between sperm and oocyte during fertilization, since much has been learned about how fertilin b, fertilin a and cyritestin participate in this cell±cell interaction. However, some data suggest the possibility that metalloprotease activity (perhaps of an ADAM or another protein) may play a role in gamete membrane interactions (Dõ Âaz-Pe Ârez et al., 1988; Correa et al., 2000) and there are ADAM family members that are candidates for this (Zhu et al., 1999 .
Fertilin a, fertilin b and cyritestin undergo proteolytic processing between the metalloprotease and disintegrin domains, so that only the disintegrin domain, the cysteine-rich domain and the EGF-like repeat remain on the surface of the mature sperm ( Figure 1 ). Fertilin a is processed intracellularly during spermatogenesis in the testis (Lum and Blobel, 1997) . Cyritestin and fertilin b are cleaved during epididymal transit of the sperm (Blobel et al., 1990; Linder et al., 1995; Hunnicutt et al., 1997; Lum and Blobel, 1997; Yuan et al., 1997; . These sperm ADAM proteins are localized to regions of the sperm head (Phelps et al., 1990; Hardy et al., 1997; McLaughlin et al., 1997; Yuan et al., 1997) .
Numerous functional studies have provided evidence that fertilin a, fertilin b and cyritestin participate in sperm±oocyte adhesion. As noted above, an anti-fertilin b monoclonal antibody, PH-30, blocked sperm±oocyte fusion of guinea pig oocytes (Primakoff et al., 1987) . Since that original study in 1987, multiple types of reagents, including antibodies, peptides and isolated proteins, have been used to examine the roles of these proteins in gamete membrane interactions. Antibodies that crossreact with these proteins bind to sperm and inhibit fertilization in IVF assays (Primakoff et al., 1987; Hardy et al., 1997; Yuan et al., 1997) . Recombinant forms of fertilin a, fertilin b and cyritestin bind to the mouse oocyte plasma membrane, and in IVF assays these proteins inhibit sperm±oocyte binding and reduce the incidence of fertilization (Evans et al., 1997a (Evans et al., ,b, 1998 Bigler et al., 2000; Zhu et al., 2000; Takahashi et al., 2001; Wong et al., 2001; Eto et al., 2002; Zhu and Evans, 2002) . In a similar fashion, peptides corresponding to the fertilin b disintegrin loop inhibit sperm binding and reduce fertilization in the mouse (Almeida et al., 1995; Evans et al., 1995b; Yuan et al., 1997; Gupta et al., 2000; Zhu et al., 2000; McLaughlin et al., 2001) , guinea pig (Myles et al., 1994) and human and non-human primate sperm with ZP-free hamster oocytes (Gichuhi et al., 1997) and with homologous oocytes (Bronson et al., 1999b; Mwethera et al., 1999) . Fertilin b disintegrin loop peptides and antibodies against the fertilin b disintegrin loop also inhibit the binding of recombinant fertilin b to oocytes (Evans et al., 1997a; Bigler et al., 2000) , indicating that fertilin b uses its disintegrin loop to bind to cognate binding partners on the oocyte surface. There are also similar data supporting the role of the mouse cyritestin disintegrin loop (Linder and Heinlein, 1997; Yuan et al., 1997; McLaughlin et al., 2001; Takahashi et al., 2001) .
Structure±function studies of the disintegrin loops of mouse fertilin b and cyritestin have revealed similar functional motifs: ECDV in fertilin b (Bigler et al., 2000; Zhu et al., 2000; Takahashi et al., 2001) and QCD with some involvement of anking sequences in cyritestin (Takahashi et al., 2001) . Recent experimental data suggest that fertilin b and cyritestin could recognize the same receptor (discussed in more detail below) (Eto et al., 2002) . Structure±function analysis of mouse fertilin a has also been performed. Unlike fertilin b, a recombinant form of fertilin a that lacks the disintegrin domain or has a truncated disintegrin domain inhibits sperm±oocyte binding (Evans et al., 1997b (Evans et al., , 1998 Wong et al., 2001) . This suggests that the cysteinerich domain and/or the EGF-like repeat of fertilin a participate in fertilin a-mediated cell adhesion; this is similar to what has been observed for ADAM12 (Iba et al., 1999) . A recombinant form of the fertilin a disintegrin domain also binds to mouse oocytes and inhibits sperm±oocyte binding (Wong et al., 2001) , demonstrating that this domain is also involved in fertilin a-mediated adhesion. Interestingly, peptides from the fertilin a disintegrin loop do not inhibit sperm±oocyte binding (Yuan et al., 1997) or the binding of recombinant fertilin a disintegrin domain to oocyte (Wong et al., 2001) , raising the possibility that other amino acids are involved in the interaction of the fertilin a disintegrin domain with cognate binding partners on the oocyte surface.
Important insights have come from studies of fertilin b and cyritestin knockout mice. Sperm from both fertilin b and cyritestin knockout mice show reduced binding to the oocyte plasma membrane, although some of the few sperm that bind are able to fuse with the oocyte membrane and fertilize and activate oocytes (Cho et al., 1998; Nishimura et al., 2001) . Surprisingly, sperm from these knockout male mice have some other, unanticipated defects. In addition to adhering poorly to the oocyte plasma membrane, sperm from fertilin b and cyritestin knockout mice also adhere poorly to the ZP (Cho et al., 1998; Shamsadin et al., 1999; Nishimura et al., 2001) , and fertilin b knockout sperm show de®cient migration from the uterus to the oviduct (Cho et al., 1998) . Considering that fertilin b knockout males mate normally and their sperm have normal motility, this suggests a defect in sperm migration to the oviduct or interaction with the oviduct walls. [Cyritestin knockout sperm, in contrast, have normal transit into the oviduct (Shamsadin et al., 1999; Nishimura et al., 2001 ).] Does this mean that fertilin b or cyritestin is involved with ZP binding, or that fertilin b is involved in migration to or interaction with the oviduct? This is one possible interpretation, but there are others. Analysis of protein expression pro®les of fertilin b and cyritestin knockout sperm reveals that: (i) fertilin b knockout sperm lack fertilin a and have greatly reduced amounts of cyritestin; and (ii) cyritestin knockout sperm lack fertilin a and have~50% of the wild-type amount of fertilin b (Nishimura et al., 2001 ). These multiple molecular de®ciencies are likely to contribute to the defects in gamete membrane interactions and possibly also to other sperm function de®ciencies. It can also be speculated that the ZP binding defect and/or oviductal transit are disrupted due to protein expression abnormalities. In other words, sperm from fertilin b knockout males that lack fertilin b, fertilin a and cyritestin could also lack a protein critical for interaction with the ZP or the oviduct.
Why might sperm from these knockout mice have abnormal protein expression pro®les? Some insight comes from a different knockout mouse, lacking a chaperone protein (called calmegin) expressed in the endoplasmic reticulum of developing sperm. Sperm from calmegin knockout males have almost exactly the defects in sperm function as do sperm from fertilin b knockout males: reduced transit into the oviduct, reduced adhesion to the ZP, and reduced adhesion to the oocyte plasma membrane (Ikawa et al., 1997 (Ikawa et al., , 2001 . Sperm from calmegin knockout males also have greatly reduced levels of fertilin b (Ikawa et al., 2001) , indicating that this knockout also has an abnormal protein expression pro®le. Calmegin appears to function as a chaperone to help protein folding; it interacts with newly synthesized proteins (including fertilin a and fertilin b) in the endoplasmic reticulum during spermatogenesis (Ikawa et al., 1997 (Ikawa et al., , 2001 ). This suggests that in a calmegin knockout mouse, fertilin a and fertilin b are left to`fend for themselves' in the endoplasmic reticulum, and this in turn leads to abnormalities, including the disappearance of fertilin b from sperm (Ikawa et al., 2001) . It can be speculated that other proteins are also adversely affected, by misfolding and/or by misexpression. These problems could then lead to the fertilization function defects observed in calmegin knockout male mice. The angiotensin-converting enzyme (ACE) knockout also has a Figure 1 . Schematic diagram of sperm and oocyte molecules known to participate in gamete membrane interactions. The diagram shows the approximate relationship of sperm and oocyte adhesion molecules and associated membrane proteins. As noted in the text, CRISP1 is not an integral membrane protein of the sperm, but a protein that associates with the sperm (by an as yet uncharacterized mechanism) during epididymal maturation. It is not known if there is a binding partner for CRISP1 on the sperm or on the oocyte (it is drawn as a peripheral membrane protein on the sperm, rather than receptor-bound). Fertilin a and fertilin b are shown associated as a dimer (Primakoff et al., 1987; Waters and White, 1997; Cho et al., 2000) . Asterisks next to domains of fertilin a, fertilin b and cyritestin indicate the domains that participate in adhesion mediated by these molecules (Evans et al., 1998; Bigler et al., 2000; Zhu et al., 2000; Takahashi et al., 2001; Wong et al., 2001) . A single integrin is shown in the oocyte plasma membrane as an a/b heterodimer. This integrin could be one of several integrins (a 9 b 1 and possibly a v b 1 , a v b 3 , a 6 b 1 ; see text for details). The ligand binding site of integrins is composed of regions in the globular heads of both the a and b subunits (additional information in Evans, 2001) ; the heads are presented on extended stalks (Xiong et al., 2001) . EGF = epidermal growth factor. similar phenotype. ACE is present in the blood, is expressed in the testis, and is also present in epididymal¯uid. Sperm from ACE knockout mice have defects in transit up the oviduct and in ZP binding (Hagaman et al., 1998) . Whilst it is unclear exactly why the ACE knockouts have these defects, one possibility is that sperm from these mice might have an abnormal protein pro®le on their surfaces due to defects in epididymal maturation.
To date, functional fertilin a and cyritestin genes have not been identi®ed in humans. Fertilin a and cyritestin genes were determined to be non-functional pseudogenes Grzmil et al., 2001) , having numerous point mutations that introduce frameshifts and premature stop codons and thus being unable to produce functional protein. In fact, several human testis-speci®c ADAM genes are intronless or non-functional pseudogenes Frayne et al., 1999; Poindexter et al., 1999) . The fact that humans are essentially fertilin a and cyritestin knockouts (lacking functional fertilin a and cyritestin genes) and yet have a different phenotype from cyritestin knockout mice suggests at least two possibilities. It could be that fertilin a and cyritestin are not essential for human gamete membrane interactions, and are also not required for a proper sperm protein expression pro®le. While fertilin a forms heterodimers with fertilin b in guinea pig, bovine and mouse sperm (Primakoff et al., 1987; Blobel et al., 1990; Waters and White, 1997; Cho et al., 2000) , it could be that fertilin b functions by itself in human sperm, as a monomer (or homomultimer) without fertilin a. Alternatively, it could be that some other proteinÐperhaps another ADAM proteinÐplays the same role and substitutes for fertilin a and cyritestin in human sperm. Thirteen members of the ADAM family are expressed predominantly in the testis [fertilin b, cyritestin, ADAM5 (tMDCII), ADAM6, ADAM16 (xMDC16), ADAM18 (tMDCIII), ADAM20, ADAM21, ADAM24 (testase 1), ADAM25 (testase 2), ADAM26 (testase 3), ADAM29, ADAM30]. Five of these testis ADAMs (fertilin b, cyritestin, ADAM5, ADAM16, ADAM18) are known to be expressed as proteins on male germ cells and/or mature sperm in at least one species. Several ADAMs, including some that are expressed in the testis, are similar to and closely related to fertilin a or cyritestin (Poindexter et al., 1999; Yoshinaka et al., 2002 ; for phylogenetic trees of ADAM family members), and two fertilin a genes, dubbed ADAM1a and ADAM1b, were recently identi®ed in the mouse (Nishimura et al., 2002) . An additional candidate is ADAM15, as recombinant mouse ADAM15 disintegrin domain was recently shown to bind to oocytes and inhibit sperm±oocyte binding (Eto et al., 2002) . It should be noted that this effect could be non-speci®c, since ADAM15, fertilin b, cyritestin, fertilin a and other ADAMs have been proposed to recognize the same receptor, the integrin a 9 b 1 (discussed in more detail below). It is not known if ADAM15 protein is expressed on sperm; ADAM15 mRNA is detected in Northern blots of human and mouse testis and many other tissues (Kra Ètzschmar et al., 1996b; Lum et al., 1998) . ADAM5 is not a candidate to participate in human gamete membrane adhesion, as it is also a pseudogene in humans (Frayne et al., 1999) .
Oocyte integrins
Integrins as well as other cell adhesion molecules (e.g. cadherins, immunoglobulin superfamily members, etc.) have been speculated to mediate sperm±oocyte adhesion, as they mediate somatic cell adhesion. In particular, ever since the identi®cation of an integrin ligand-like, disintegrin domain in fertilin b and cyritestin [and later in fertilin a (Lum and Blobel, 1997; Waters and White, 1997)], it was hypothesized that that these sperm ligands could bind to integrins on the oocyte membrane. Therefore, the issue of the role of oocyte integrins in gamete membrane interactions has two aspects: (i) whether oocyte integrins participate in gamete interactions in general; and (ii) whether oocyte integrins recognize sperm ADAMs.
Integrins are a family of heterodimeric cell adhesion molecules that mediate cell±cell and cell±extracellular matrix interactions. To date, 18 a subunits and eight b subunits have been identi®ed, and these combine to make 24 different integrins. These 24 integrins can be divided into six subfamilies based on sequence homologies between the a subunits and the general characteristics of ligands recognized by integrin heterodimers containing each a subunit.
Several integrin subunits have been detected in mammalian oocytes at the mRNA or protein level, including a 2 , a 3 , a 4 , a 5 , a 6 , a v , a 9 , a M , b 1 , b 2 , b 3 and b 5 (Fusi et al., 1992 (Fusi et al., , 1993 Anderson et al., 1993; Tarone et al., 1993; Almeida et al., 1995; Evans et al., 1995a; de Nadai et al., 1996; Linfor and Berger, 2000; Neilson et al., 2000; Stanton and Green, 2001 ). The involvement of the RGD-binding subfamily of integrins (a 5 b 1 ,
has been suggested by the inhibition of interactions of human and hamster sperm with ZP-free hamster and human oocytes by RGD peptides (Bronson and Fusi, 1990; Ji et al., 1998) . RGD peptides do not have a substantial inhibitory effect on mouse gamete interactions (Almeida et al., 1995; Evans et al., 1995b) , although they do have a modest inhibitory effect on the binding of recombinant fertilin b to mouse oocytes (Zhu and Evans, 2002) . Biochemical analyses have implicated a v and b 1 integrin subunits on the pig oocyte in the recognition of isolated pig sperm membrane proteins (Linfor and Berger, 2000) . A few anti-integrin antibodies have been reported to affect gamete interactions in IVF assays. Anti-b 1 antibodies have a moderate inhibitory effect on mouse, human and pig sperm±oocyte interactions (Evans et al., 1997a; Ji et al., 1998; Linfor and Berger, 2000) and also on the binding of recombinant fertilin b to mouse oocytes (Evans et al., 1997a ). An anti-a 6 function-blocking monoclonal antibody, GoH3, inhibits mouse sperm±oocyte interactions in some (Almeida et al., 1995) but not all IVF assays (Evans et al., 1997a; Evans, 1999; Miller et al., 2000) . Moreover, the ®ndings that oocytes from a 6 knockout mice and oocytes with undetectable amounts of a 6 GoH3 epitope are capable of being fertilized strongly suggest that oocyte a 6 is not required for fertilization (Evans et al., 1997a; Miller et al., 2000) . It should be noted that it is extremely dif®cult to study oocytes from integrin knockout mice, since many integrins are widely expressed in the body and thus many integrin knockouts die pre-or peri-natally, well before reaching sexual maturity (Hynes, 1996 ; De Arcangelis and Georges-Labouesse, 2000). As a 6 knockout mice die shortly after birth, the study of oocytes from the a 6 knockout mice required the isolation of ovaries from newborns, and transplanting these ovaries into the kidney capsule bursal cavity of ovariectomized mice to allow the ovaries to develop to the point where oocytes could be retrieved from them (Cox et al., 1996; Miller et al., 2000) .
Despite these technical challenges, there are other ways to examine the possible role of oocyte integrins in gamete membrane interactions. One way is to consider data from other experimental systems. To date, eight different ADAM family members have been reported to interact with six different integrins (Table I) , based primarily on assays of adhesion of integrin-expressing cells to ADAM proteins, in some cases combined with antibody and peptide inhibition studies. Members of three different integrin subfamilies appear to interact with ADAMs, with several of these integrins expressed by oocytes. With these ®ndings in mind, what are the data that suggest these oocyte integrins could actually interact with an ADAM on sperm? a 4 b 1 and a 9 b 1 are members of the same integrin subfamily; this subfamily has three members (a 4 b 1 a 4 b 7 , a 9 b 1 ). These integrins recognize a diverse array of ligands, including vascular cell adhesion molecule (VCAM)-1, osteopontin, tenascin-C, ®bronectin and Mad-CAM-1, and in several cases recognizing a conserved amino acid sequence motif containing an Asp residue in these proteins (Evans, 2001; summary) . As shown in Table I , seven of the eight ADAMs thus far demonstrated to bind to an integrin, including the three sperm ADAMs (fertilin a, fertilin b, cyritestin), can interact with a member of the a 4 /a 9 subfamily (Eto et al., 2000 (Eto et al., , 2002 Bridges et al., 2002) . With regard to gamete membrane interactions, a member of the a 4 /a 9 subfamily has been implicated by two results. Somatic cells expressing a 9 b 1 adhere to recombinant fertilin a, fertilin b and cyritestin (Eto et al., 2002) . In addition, the binding of recombinant fertilin b to mouse oocytes is inhibited by a peptide sequence, MLDG, that perturbs adhesion mediated by the a 4 /a 9 integrins (Zhu and Evans, 2002) . The a 4 subunit has been reported to be present on hamster oocytes (de Nadai et al., 1996) , but expression is weak or absent on human oocytes (Campbell et al., 1995; de Nadai et al., 1996) and mouse oocytes (J.P.Evans, unpublished data). a 9 cDNA is detected in a pool of expressed sequence tags from mouse oocyte cDNA libraries (Stanton and Green, 2001) , although the protein has not been detected. Thus, the possibility remains that an integrin related to but distinct from a 4 b 1 , a 9 b 1 and a 4 b 7 is expressed by oocytes and mediates adhesion to sperm ADAMs. The identity of this oocyte integrin remains to be de®nitely determined.
a 6 b 1 is a member of the subfamily of integrins that primarily recognize laminins, and has been suggested to participate in fertilization (Almeida et al., 1995; Bigler et al., 2000; Takahashi et al., 2001) . It is also implicated as a receptor for fertilin b and cyritestin based on a chemical cross-linking study with a fertilin b peptide (Chen and Sampson, 1999) and from studies with an antia 6 function-blocking monoclonal antibody (Almeida et al., 1995; Bigler et al., 2000; Takahashi et al., 2001) . However, other attempts to inhibit interactions of fertilin b and other ADAMs with oocytes and other cells using the same anti-a 6 antibody have been unsuccessful (Evans et al., 1997a; Eto et al., 2002; Zhu and Evans, 2002) . It is a formal possibility that fertilin b recognizes a site on a 6 b 1 that is not blocked by this anti-a 6 antibody. However, as noted above, a 6 is not required for fertilization (Miller et al., 2000) . More recently, there has been speculation that oocyte a 6 b 1 has a role in ADAM binding perhaps not as a direct binding partner but as a component of a multi-molecular complex in the oocyte plasma membrane (Bigler et al., 2000; Takahashi et al., 2001) ; this is addressed in more detail in the section below on oocyte tetraspanins.
Finally, a V b 3 , a v b 5 and a 5 b 1 are members of the RGD-binding subfamily that mediate adhesion to ligands such as ®bronectin, vitronectin and ®brinogen by binding to an RGD motif in the ligand in most cases. Members of the RGD-binding integrin subfamily are expressed by oocytes (see above) and are implicated in fertilization by studies using RGD peptides in IVF assays (Bronson and Fusi, 1990; Ji et al., 1998) and other work (Linfor and Berger, 2000) . With regard to the potential role of these integrins in the recognition of a sperm ADAM, RGD peptides have a moderate inhibitory effect on the binding of fertilin b to mouse oocytes (Zhu and Evans, 2002) . While one possible explanation for this is that an RGD-binding integrin contributes to fertilin b binding, it is also possible that the RGD peptide is weakly perturbing an a 4 /a 9 integrin on the oocyte surface (as these integrins recognize sequences in some ligands that have some weak similarities to RGD motifs). Therefore, the exact roles of RGD-binding integrins in gamete sperm ADAMmediated adhesion as well as the identi®cation of speci®c family members on oocytes that could be involved remain to be fully characterized.
Oocyte tetraspanins
Tetraspanins (also known as tetraspans or TM4SF proteins) are a family of proteins with the conserved structural features of four membrane-spanning regions (hence the name) and two extracellular loops (one large, one small), with a series of other conserved residues (Berditchevski, 2001; Boucheix and Rubinstein, 2001; Hemler, 2001) . It should be noted that not every protein with four membrane-spanning regions is a bona ®de tetraspanin. To date, 28 mammalian tetraspanin family members 
ADAM15 (Zhang et al., 1998; Nath et al., 1999) ADAM23 (Cal et al., 2000) 
ADAM15 (Nath et al., 1999) a 4 b 1 a 4 /a 9 subfamily (a 4 b 1 a 4 b 7 , a 9 b 1 ) ADAM28 (Bridges et al., 2002) have been described, and several of these are implicated in a variety of cellular and physiological processes, such as cell adhesion, motility, proliferation and differentiation (Boucheix and Rubinstein, 2001; Hemler, 2001) . Tetraspanins in general do not appear to function as receptors for extracellular ligands, but they do associate in the plane of the lipid bilayer with other membrane proteins, including other tetraspanins, integrins, immunoglobulin superfamily members, proteoglycans, complement regulatory proteins, growth factors receptors and others (Hemler, 1998; Berditchevski and Odintsova, 1999; Woods and Couchman, 2000; Boucheix and Rubinstein, 2001; Hemler, 2001 ). These intramembrane (or lateral or cis) associations form complexes referred to as tetraspanin webs. One member of this family, CD9, plays a key role in gamete membrane interactions. Although CD9 is widely expressed in the body, the phenotype of the knockout mouse shows speci®c effects on female fertility. CD9 knockout females appear to ovulate normally, and yields of oocytes from super-ovulated animals are similar to yields from knockouts. Oocyte maturation to metaphase II also appears to be normal. However, oocytes from CD9 knockout mice are rarely fertilized (Kaji et al., 2000; Le Naour et al., 2000; Miyado et al., 2000) . Sperm are observed in the perivitelline space of ZP-intact oocytes fertilized in vivo or in vitro, apparently unable to undergo sperm±oocyte fusion and lead to fertilization and oocyte activation (Le Naour et al., 2000; Miyado et al., 2000) . Sperm are able to adhere to the plasma membrane of ZP-free CD9 knockout oocytes, but very rarely fuse with the oocyte membrane [between three reports, only three of 246 ZP-free oocytes were fertilized (Kaji et al., 2000; Le Naour et al., 2000; Miyado et al., 2000) ]. However, CD9 knockout females did, on rare occasions, conceive and give birth to pups. In addition, oocytes from CD9 knockout mice could be fertilized by ICSI and these embryos developed to term (Miyado et al., 2000) . If the expression of CD9 is induced in CD9 knockout oocytes (via microinjection of CD9 mRNA), the ability of the oocytes to be fertilized can be restored . Using this method, a structure±function analysis of CD9 has been performed. Two mutated forms of CD9, a point mutation of amino acid 174 and the triple mutation of amino acids 173±175 [F174A and SFQ(173±175)AAA respectively] very poorly rescue the ability of CD9 knockout oocytes to be fertilized , suggesting that the SFQ motif in this region has a critical function in mouse oocyte CD9.
The observation that sperm adhere to the CD9 knockout oocyte plasma membrane but do not fuse is suggestive of a role for CD9 in sperm±oocyte fusion. Questions have been raised as to whether CD9 may play a role, direct or indirect, in sperm±oocyte adhesion. IVF results with anti-CD9 antibodies are con¯icting; ZP-free oocytes treated with anti-CD9 monoclonal antibodies have been reported to have reduced numbers of bound sperm Takahashi et al., 2001) , whereas another report states that sperm binding was unaffected by an anti-CD9 antibody (Miller et al., 2000) . Additionally, treatment of oocytes with a recombinant form of the large extracellular loop of CD9 leads to a reduction in sperm±oocyte fusion when the oocytes are inseminated, with no effects on sperm±oocyte binding . Other data do suggest a role for CD9 in sperm±oocyte adhesion. ZP-free oocytes treated with anti-CD9 antibodies show reduced levels of binding of the sperm ligands cyritestin (Takahashi et al., 2001) , fertilin a (Wong et al., 2001 ) and fertilin b Zhu and Evans, 2002) . The inhibitory activity of anti-CD9 antibodies on the binding of fertilin a and fertilin b depends on the presentation of the sperm ligand to oocytes in the binding assays. The binding of multimeric forms (immobilized on small beads) of fertilin a and fertilin b is inhibited by an anti-CD9 antibody, whereas soluble monomeric forms of these sperm ligands still appear to bind (Wong et al., 2001; Zhu and Evans, 2002) . Similar inhibition of binding of beads coated with cyritestin and fertilin b has been observed with a different anti-CD9 antibody Takahashi et al., 2001) . While the signi®cance of this is unclear, it could be suggestive of a role for CD9 to strengthen adhesions mediated by these sperm ADAMs rather than the initial molecular interaction of sperm ligand to oocyte receptor. The connection between this and the ®nding that sperm can bind to CD9 knockout oocytes is not known, although it is likely that the action of functionblocking antibodies is distinctly different from the effect of having no CD9 present in the oocyte membrane. Furthermore, results with different anti-CD9 monoclonal antibodies Miller et al., 2000; Takahashi et al., 2001; Wong et al., 2001; Zhu and Evans, 2002) as well as structure±function analysis of CD9 raise the possibility that different portions of CD9 may have functions in adhesion and fusion.
Tetraspanins, as noted above, are components of multimolecular complexes or networks in the plasma membrane. These networks include integrins, other types of tetraspanins, and other membrane proteins. Several different integrins are expressed by oocytes (see details above), and at least seven different tetraspanins (CD9, CD81, CD82, CD151, SAS, Tspan-3 and Tspan-5) and various tetraspanin-associated proteins are potentially expressed in mouse or human oocytes (Neilson et al., 2000; Stanton and Green, 2001) . The participation of some of these network components in fertilization is beginning to be examined. CD81 is expressed on the mouse oocyte membrane, but anti-CD81 antibodies do not inhibit sperm or recombinant cyritestin binding to oocytes, whereas anti-CD9 antibodies do inhibit these interactions (Takahashi et al., 2001) . However, there is some suggestion that CD81 knockout mice may have fertility problems [reduced reproductive capacity after repeated back-crosses (Deng et al., 2000) ], although the cause of this is not known. Antibodies that cross-react with CD98, another type of protein that associates with integrins and tetraspanins, inhibit sperm or recombinant cyritestin binding to oocytes (Takahashi et al., 2001) . Finally, as discussed above, the integrin a 6 b 1 has been implicated in oocyte interactions with fertilin b and cyritestin on sperm (Bigler et al., 2000; Takahashi et al., 2001) , although studies of oocytes from a 6 knockout mice demonstrate that a 6 expression by oocytes is not required for fertilization (Miller et al., 2000) . In other cell types, a 6 b 1 can interact with several members of the tetraspanin family (CD9, CD63, CD81, CD82, CD151) and many tetraspanins can interact laterally with at least one member of the laminin-binding family of integrins [a 6 b 1 , a 3 b 1 , a 6 b 7 and a 7 b 1 (Berditchevski, 2001; Boucheix and Rubinstein, 2001) ]. CD9 and a 6 b 1 can associate in the mouse oocyte membrane (Miyado et al., 2000) , although oocytes lacking a 6 still express CD9 on their plasma membranes and fertilization of these oocytes is inhibited with anti-CD9 antibodies (Miller et al., 2000) . Relatively little is known about tetraspanin complexes in the oocyte membrane, but further characterization of these complexes in oocyte membranes should shed light on the mechanisms of action of these molecules in mediating adhesion and fusion with sperm.
Other candidate molecules
Fertilin a and fertilin b are two of the best characterized antigens identi®ed by screening a battery of sperm surface monoclonal antibodies. However, it is worth noting that although many more gamete antigens have been identi®ed by this method, these antigens and/or their role in fertilization has not been characterized as extensively as those of the PH-30 antigen. Examples include the sperm antigens for monoclonal antibody MH61 (Okabe et al., 1990) [which has been identi®ed as CD46/ membrane cofactor protein (MCP) (Okabe et al., 1992) ], monoclonal antibody MN9 [the antigen of which has been named equatorin (Toshimori et al., 1992 (Toshimori et al., , 1998 ] and others (Saling et al., 1985; Okabe et al., 1988; Allen and Green, 1995; Noor and Moore, 1999) . CD46 is one protein that can laterally associate with integrins and tetraspanins (Lozahic et al., 2000) , although CD46 was not detected in the membranes of human oocytes (Fenichel et al., 1995) . There are other candidate molecules hypothesized to be involved in gamete membrane interactions. These include extracellular matrix molecules, sulphoglycolipids and components of the complement pathway, including C3b and its receptors CD46/MCP and the integrin a M b 2 , and also C1q and its receptors (Evans, 1999; review) . A GPI-anchored protein(s) on oocytes has been implicated by a study in which oocytes treated with phosphatidylinositol-speci®c phospholipase C (which removes GPI-anchored proteins) show a greatly reduced ability to support sperm adhesion and fusion . A 94 kDa protein on oocytes has been implicated by studies in which oocytes treated with proteases show a greatly reduced ability to support sperm adhesion and fusion, and reappearance of a 94 kDa protein correlated with recovery of the ability of the oocytes to be fertilized (Kellom et al., 1992) . A metalloprotease (on either sperm or oocyte) has been implicated by studies in which treatment of gametes with metalloprotease inhibitors at the start of insemination leads to decreased fertilization (Correa et al., 2000) .
A model of how mammalian sperm±oocyte adhesion and fusion may occur
Gamete membrane interactions involve cell adhesion and then membrane fusion. Fertilin a, fertilin b and cyritestin on sperm and integrins on oocytes appear to mediate the adhesion process. CRISP1 may be involved in adhesion or fusion. CRISP1 protein puri®ed from rat epididymal extracts binds to the oocyte plasma membrane and inhibits sperm±oocyte fusion in IVF of ZP-free rat oocytes, apparently without affecting sperm±oocyte adhesion . However, CRISP1 does not have homology to proteins known to be involved in membrane fusion events, and current speculation places CRISP1 upstream of fusion . Fertilin a was originally a candidate to mediate membrane fusion between the gametes (Blobel et al., 1992) , but the ®nding that the fertilin a-lacking sperm from fertilin b and cyritestin knockout mice are still capable of membrane fusion has dispelled this theory (Shamsadin et al., 1999; Nishimura et al., 2001) . CD9 has been implicated in certain types of membrane fusions (Schmid et al., 2000; Boucheix and Rubinstein, 2001 ), but it is not known if CD9 in the oocyte has a direct role in facilitating gamete fusion, or has an upstream action such as by enhancing sperm interactions or modulating the oocyte membrane environment to make it`fusion competent'. Results with two different monoclonal antibodies Miller et al., 2000; Takahashi et al., 2001; Wong et al., 2001; Zhu and Evans, 2002) as well as structure±function analysis of CD9 raise the possibility that different portions of CD9 may have functions in sperm adhesion or gamete fusion, although this remains to be fully elucidated. Nevertheless, one intriguing theme that has emerged is the importance of multimeric complexes and a proper membrane environment on both sperm and oocyte for gamete membrane interactions to be successful. In the case of the oocyte, CD9 appears to be a key component of these multimeric complexes. In the case of sperm, insight into the importance of multimeric membrane protein complexes has come from analyses of protein expression pro®les of sperm from the fertilin b and cyritestin knockout mice (Nishimura et al., 2001) . Disruption of the membrane environment by an antibody treatment, a gene knockout removing a key component or other means, appears to lead to suboptimal membrane order that is less capable of supporting gamete adhesion and/or fusion.
The adhesion of sperm to oocyte is frequently cited as likely to be analogous to the mechanism by which leukocytes interact with endothelial cells. In this cell±cell interaction system, the adhesions occur in a step-wise fashion, starting with initial attachments (also called rolling or tethering) and leading to ®rm adhesion bringing the two membranes into close apposition; ®nally, the leukocytes undergo extravasation, traversing the endothelium to exit from the bloodstream. In the leukocyte± endothelium system, distinct ligand±receptor pairs with speci®c kinetics and af®nities mediate each of the speci®c adhesion steps. Rolling is mediated by selectin±carbohydrate interactions that have rapid kinetics, followed by ®rmer adhesions supported ®rst by the integrin a 4 b 1 on the leukocyte binding endothelial VCAM-1, and then interactions of a L b 2 and a M b 2 with intracellular adhesion molecules (Brown, 1997; Worthylake and Burridge, 2001) . Sperm±oocyte membrane interactions also appear to occur in a step-wise fashion, in terms of the spatial domains of the sperm head that interact with the oocyte (see above) and possibly also in terms of the molecules involved.
A hypothetical model for how gamete membrane adhesion leads to fusion is shown in Figure 2 . This model is based on membrane fusion events between cells and virus particles (Lentz et al., 2000; Eckert and Kim, 2001) . In many virus±cell interactions, membrane fusion is mediated by a viral fusion protein in the membrane of the viral envelope. The viral fusion protein contains a hydrophobic subdomain, called a fusion peptide, which is folded within the fusion protein so that its hydrophobic amino acids are not exposed to the aqueous environment until a conformation change occurs to expose it. In the hypothetical model in Figure 2 , panel A shows adhesion mediated by receptor±ligand pairs labelled 1 and 2; the adhesion between receptor±ligand pair 2 has induced bending of the lipid bilayers, bringing the two membranes into closer apposition. A putative fusion protein is shown with the hydrophobic fusion peptide concealed. (Please note that the two plasma membranes shown are purposely not identi®ed as sperm and oocyte, since the mechanism could work with these proteins in either gamete.) In panel B, the fusion protein has undergone a conformational change to expose the fusion peptide, which then inserts in the opposing bilayer. Next, the facing outer lea¯ets of two lipid bilayers intermingle, a state called hemifusion (shown in panel C). Finally, panel D shows the formation of an opening, called a fusion pore, between the two membranes, connecting the cytoplasms of the two cells. The fusion pore then expands, ultimately incorporating one membrane into the other. It should be emphasized that this is only a possibility for how mammalian gamete membrane interactions occur, although recent analysis of invertebrate sperm proteins has identi®ed hydrophobic regions that might function by a mechanism somewhat similar to that of viral fusion peptides (Ulrich et al., 1998; Glaser et al., 1999; Kresge et al., 2001) .
A second model for membrane fusion comes from studies of membrane fusion between intracellular vesicles with other membranes during traf®cking, mediated by transmembrane proteins known as soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor (SNARE) proteins and cytoplasmic accessory proteins that regulate SNARE function (Lentz et al., 2000; Chen and Scheller, 2001) . A v-SNARE on a vesicle interacts with a t-SNARE on a target membrane, and these are believed to intertwine and form bundles of a-helices, bringing the vesicle and target membranes into close apposition, analogous to the way in which a viral fusion protein brings membranes close together after insertion of the fusion peptide, leading to formation of the fusion pore. It is possible that there are SNARE-like proteins on the extracellular surface of the sperm and oocyte that mediate gamete fusion. However, it should be emphasized that the SNARE model is based on membrane fusion events that occur on the interior of cells, with fusion being initiated by the membrane proteins and lipids that face the cytoplasm. Sperm±oocyte (and other cell±cell) fusion events are different in this regard, occurring on the extracellular surfaces of membranes and thus initiated by membrane proteins and lipids that face the extracellular space. While some SNARE machinery has been detected in gametes and is postulated to mediate acrosome and cortical granule exocytosis, it is unclear if it participates in plasma membrane fusion (Ramalho-Santos et al., 2000) . Finally, metalloprotease activity may play a role in gamete membrane fusion (Dõ Âaz-Pe Ârez et al., 1988; Correa et al., 2000) Concluding thoughts
The advancement of our knowledge of the molecular basis of events surrounding fertilization, including gamete membrane interactions, has paled in comparison with the speed with which assisted reproductive technologies have been developed. The most obvious procedure that affects gamete membrane interactions is ICSI, which actually bypasses membrane interactions altogether. Other clinical procedures may impact fertilization as well, such as by affecting oocyte or sperm maturation. For example, expression of CRISP1 mRNA and protein in the rat epididymis is reduced after androgen ablation (Cameo and Blaquier, 1976; Roberts et al., 2001) , after depletion of testicular factors from epididymal¯uid (Turner and Bomgardner, 2002) and after vasectomy (Turner et al., 1999) , and is not recovered after vasovasostomy (Turner et al., 2000) . This may have implications for male infertility and for patients hoping to recover fertility after vasovasostomy. It is not known (but is conceivable) that other epididymal functions, such as processing of fertilin b or cyritestin, might also be adversely affected by vasectomy and not recovered after vasovasostomy.
Proper gamete membrane interactions may do much more than simply merge two cells into one. These cellular processes introduce the paternal DNA, the sperm centriole and perhaps an oocyte activating factor to the oocyte in a precisely regulated fashion. While ICSI does result in oocyte activation, plasma membrane interactions between gametes may be important for correct temporal and spatial patterns of calcium signalling upon oocyte activation (Tesarik et al., 1994; Nakano et al., 1997; Sato et al., 1999; Deguchi et al., 2000) and/or for patterning of early embryonic development (Piotrowska and Zernicka-Goetz, 2001 ). Thus, plasma membrane interactions between the gametes as well as other events around the time of conception could contribute to the success (or failure) of embryo and fetal development.
